SI-BONE, Inc.
$14.32
▲
0.85%
2026-04-21 09:24:01
si-bone.com
NGM: SIBN
Explore SI-BONE, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$632.45 M
Current Price
$14.32
52W High / Low
$21.89 / $12.15
Stock P/E
—
Book Value
$4.07
Dividend Yield
—
ROCE
-10.47%
ROE
-10.97%
Face Value
—
EPS
$-0.44
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
376
Beta
0.77
Debt / Equity
20.67
Current Ratio
8.55
Quick Ratio
7.21
Forward P/E
-33.66
Price / Sales
2.82
Enterprise Value
$455.95 M
EV / EBITDA
-27.53
EV / Revenue
2.27
Rating
None
Target Price
$26
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | InMode Ltd. | $14.57 | 9.84 | $923.14 M | — | 12.27% | 13.53% | $16.74 / $12.72 | $10.78 |
| 2. | INVO Fertility, Inc. | $2.28 | — | $3.39 M | — | -26.69% | -133.37% | $384 / $1.92 | $-22.34 |
| 3. | DexCom, Inc. | $63.4 | 30.77 | $24.57 B | — | 21.72% | 34.5% | $89.98 / $54.11 | $7.14 |
| 4. | TransMedics Group, Inc. | $113.13 | 20.39 | $3.88 B | — | 11.09% | 54.24% | $156 / $84.53 | $13.81 |
| 5. | Delcath Systems, Inc. | $10.88 | 139.76 | $377.34 M | — | 0.59% | 3% | $18.23 / $8.12 | $3.21 |
| 6. | WORK Medical Technology Group LTD | $1.2 | — | $1.6 M | — | -4.23% | -6.45% | $10,800 / $1.05 | $17.7 |
| 7. | Myomo, Inc. | $0.9 | — | $34.65 M | — | -47.54% | -86.24% | $4.99 / $0.6 | $0.3 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 56.35 M | 48.66 M | 48.63 M | 47.29 M | 49 M |
| Operating Profit | -2.46 M | -5.38 M | -7 M | -7.48 M | -5.49 M |
| Net Profit | -1.64 M | -4.57 M | -6.15 M | -6.54 M | -4.5 M |
| EPS in Rs | -0.04 | -0.1 | -0.14 | -0.15 | -0.1 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 200.93 M | 167.18 M | 138.89 M | 106.41 M |
| Operating Profit | -22.33 M | -35.25 M | -46.93 M | -59.61 M |
| Net Profit | -18.9 M | -30.91 M | -43.34 M | -61.26 M |
| EPS in Rs | -0.43 | -0.7 | -0.98 | -1.39 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 238.56 M | 230.44 M | 230.43 M | 157.55 M |
| Total Liabilities | 61.02 M | 63.47 M | 61.05 M | 59.25 M |
| Equity | 177.53 M | 166.96 M | 169.38 M | 98.3 M |
| Current Assets | 216.12 M | 207.78 M | 211.39 M | 137.61 M |
| Current Liabilities | 25.28 M | 27.13 M | 23.46 M | 21.18 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -0.68 M | -12.43 M | -18.71 M | -41.66 M |
| Investing CF | 4.16 M | 12.62 M | -59.8 M | -2.81 M |
| Financing CF | 3.38 M | 1.96 M | 90.93 M | 2.2 M |
| Free CF | -9.09 M | -22.92 M | -26.51 M | -51.16 M |
| Capex | -8.41 M | -10.5 M | -7.8 M | -9.51 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 20.19% | 20.37% | 30.52% | — |
| Earnings Growth % | 38.85% | 28.67% | 29.25% | — |
| Profit Margin % | -9.41% | -18.49% | -31.2% | -57.57% |
| Operating Margin % | -11.11% | -21.08% | -33.79% | -56.02% |
| Gross Margin % | 79.57% | 79.03% | 78.78% | 85.24% |
| EBITDA Margin % | -5.23% | -13.81% | -24.8% | -51.67% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.